Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
JAMA
; 327(3): 227-236, 2022 01 18.
Article
in En
| MEDLINE
| ID: mdl-35040887
Full text:
1
Database:
MEDLINE
Main subject:
Heparin
/
Purinergic P2Y Receptor Antagonists
/
COVID-19 Drug Treatment
/
Inpatients
/
Anticoagulants
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2022
Type:
Article